Specifications
An oral, phase 1 hdm2 antagonist. Binds the RING domain of MDM2 and inhibits survival in cancer cells.
Info
| Purity | >99% (TLC), NMR (conforms) |
| Quantity | 5 mg |
| Molecular Weight | 328.41 Da |
| Physical State | Lyophilized solid |
| Solubility | DMSO (66mg/ml); Ethanol (<2mg/ml); Water (<1mg/ml) |
| CAS No. | 881202-45-5 |
| Storage | 4°C, (-20°C Long term). The product can be shipped at room temperature. |
Reviews
There are no reviews yet.